# Mama — M3.1 focused independent R2 approval

Status: **APPROVED / reviewed_by_2 / still draft**.

Date: 2026-10-26.

## Reviewer privacy

The focused M3.1 review was performed by the same independent R2 physician who reviewed the M3 core.

Public repository identifier only:

`external-physician-r2-private-breast-001`

No reviewer name, professional registration, institution or other identifying metadata is stored in this repository.

The project lead attests that this handle represents the independent clinical reviewer and that the reviewer approved the final M3.1 implementation after reviewing the focused packet.

## Verdict

**APPROVE**

No mandatory clinical correction was requested for the final M3.1 implementation.

The review covered:

1. under-40 semantics:
   - SUS: `routine_not_recommended`;
   - Brasil ampliado: `routine_not_recommended`;
   - USPSTF: `outside_recommendation_scope`;
2. hard-exit precedence over routine age closure;
3. suppression of age closure when safety information is incomplete/unknown;
4. Mama-specific SharedDecision reasons;
5. strict externally-established high familial risk input contract;
6. preservation of the shallow Depth Budget;
7. canonical Mama decision-context integration of under-40 provenance.

## Frozen governance snapshot

`breast-0.1.6-m3-1-r2-reviewed-draft`

The snapshot records:

- project human gate;
- independent anonymous R2 approval;
- exact M3.1 scope version;
- exact decision-context version;
- reviewed source-backed under-40 policy resolutions;
- reviewed SharedDecision reason mapping;
- reviewed high-risk familial input contract.

## Final automated gate

After the focused R2 registration and strict-type test correction:

- schema checks: **62/62**;
- test files: **52/52**;
- tests: **633/633**;
- M3.1 focused R2 governance: **5/5**;
- Mama activation-readiness: **5/5**;
- Foundation typecheck ✅;
- CCR pilot typecheck ✅;
- Foundation build ✅;
- CCR pilot build ✅;
- V2 byte-for-byte preserved ✅.

## What this approval does NOT authorize

- lifecycle activation;
- merge;
- deploy;
- public release;
- product/UI/report activation;
- real-world clinical use.

Activation remains a separate explicit governance gate.
